Skip to main content

Table 2 Relationship between MAGE and clinical variables by univariate regression analysis

From: Nerve conduction study of the association between glycemic variability and diabetes neuropathy

  r Spearman ρ p value
Age (years) 0.028   0.86
Disease duration (years) 0.462   0.003
HbA1c (%) 0.292   0.067
BMI (kg/m2) − 0.39   0.012
SBP (mmHg) 0.045   0.78
TG (mg/dL) − 0.18   0.27
LDL (mg/dL) 0.40   0.011
eGFR (mL/min/1.73 m2) 0.014   0.70
UAE (mg/gCre)   0.13 0.41
Median CMAP amp (mV) − 0.098   0.55
Median DL (m/s) 0.032   0.84
Median MCV (m/s) − 0.27   0.088
Median F latency z score 0.057   0.72
Median wrist SNAP (µV) − 0.228   0.158
Median SCV (m/s) − 0.00   0.99
Tibial CMAP amp (mV) 0.12   0.46
Tibial MCV (m/s) − 0.043   0.79
Tibial F z score − 0.25   0.12
Sural SNAP (µV) − 0.15   0.37
Sural SCV (m/s) 0.055   0.74
Medial plantar CNAP amp (µV) − 0.32   0.042
Medial plantar NCV (m/s) − 0.033   0.849
  1. HbA1c glycated hemoglobin A1c, BMI body mass index, SBP systolic blood pressure, TG triglyceride, LDL low-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, UAE urinary albumin excretion, MAGE mean amplitude of glycemic excursions, CMAP compound muscle action potential, SNAP sensory nerve action potential, CNAP compound nerve action potential, amp: amplitude, DL distal latency, MCV motor nerve conduction velocity, SCV sensory nerve conduction velocity, NCV nerve conduction velocity